Applied Biochemistry and Microbiology

, Volume 55, Issue 1, pp 21–24 | Cite as

Modified Antiproteinase Hemosorbent

  • I. L. ValuevEmail author
  • L. I. Valuev
  • L. V. Vanchugova
  • I. V. Obydennova


A method to increase the thromboresistance of the biospecific antiproteinase hemosorbent was suggested based on simultaneous immobilization of duck egg ovomucoid and blood anticoagulant—heparin or hirudin—in the bulk of polyacrylamide hydrogel. It was demonstrated that modification of the hemosorbent with hirudin resulted in a significant increase of its compatibility with blood with simultaneous preservation of high capacity with regards to serine proteinases.


hemosorbent duck ovomucoid hirudin heparin 



This work was financially supported by the Federal Agency of Scientific Organization of Russia (theme 3, scientific direction 45, state registration АААА-А18-118011990207-1).


The authors declare that they have no conflict of interest. This article does not contain any studies involving animals or human participants performed by any of the authors.


  1. 1.
    Lopukhin, Yu.M. and Molodenkov, M.N., Gemosorbtsiya (Hemosorption), Moscow: Meditsina, 1978.Google Scholar
  2. 2.
    Shul'gin, M.N., Valueva, T.A., Kestere, A.Ya., and Mosolov, V.V., Biokhimiya, 1981, vol. 46, no. 3, pp. 473–480.Google Scholar
  3. 3.
    Plate, N.A., Valuev, L.I., Valueva, T.A., and Chupov, V.V., Biomaterials, 1993, vol. 14, no. 1, pp. 51–56.CrossRefGoogle Scholar
  4. 4.
    Kirkovsky, V.V., Antiperovich, O.F., Valueva, T.A., Moin, V.M., Lobacheva, G.A., and Berezkina, O.G., Biomaterials, 1994, vol. 15, no. 5, pp. 334–337.CrossRefGoogle Scholar
  5. 5.
    Plate, N.A., Kirkovsky, V.V., Antiperovich, O.F., Nicolaichik, V.V., Valueva, T.A., Sinilo, S.B., Moin, V.M., and Lobacheva, G.A., Biomaterials, 1994, vol. 15, no. 4, pp. P. 285–288.Google Scholar
  6. 6.
    Carr, J.A. and Silverman, N., J. Cardiovasc. Surg. (Torino), 1999, vol. 40, no. 5, pp. 659–666.Google Scholar
  7. 7.
    Ul’yanov, A.M. and Lyapina, L.A., Usp. Sovrem. Biol., 1977, vol. 83, no. 1, pp. 69–85.Google Scholar
  8. 8.
    Zubairov, D.M., Biokhimiya svertyvaniya krovi (Biochemistry of Blood Coagulation), Moscow: Meditsina, 1978.Google Scholar
  9. 9.
    Henry, B.L. and Desai, U.R., Thromb. Res., 2014, vol. 134, no. 5, pp. 1123–1129.CrossRefGoogle Scholar
  10. 10.
    Chan, H.H., Leslie, B.A., Stafford, A.R., Roberts, R.S., Al-Aswad, N.N., Fredenburgh, J.C., and Weitz, J.I., Biochemistry, 2012, vol. 51, no. 40, pp. 7964–7973.CrossRefGoogle Scholar
  11. 11.
    Mashkovskii, A.D., Lekarstvennye sredstva (Drugs), Moscow: Meditsina, 2002, vol. 2.Google Scholar
  12. 12.
    Markwardt, F., Methods Enzymol., 1970, vol. 19, pp. 924–932.CrossRefGoogle Scholar
  13. 13.
    Kovach, I.M., Kakalis, L., Jordan, F., and Zhang, D., Biochemistry, 2013, vol. 52, no. 14, pp. 2472–2481.CrossRefGoogle Scholar
  14. 14.
    Biosovmestimost' (Biocompatibility), Sevast’yanov, V.I., Ed., Moscow: GUP Informatsionnyi tsentr VNIIgeosistem, 1999.Google Scholar
  15. 15.
    Mosolov, V.V., Proteoliticheckie fermenty (Proteolytic Enzymes), Moscow: Nauka, 1971.Google Scholar

Copyright information

© Pleiades Publishing, Inc. 2019

Authors and Affiliations

  • I. L. Valuev
    • 1
    Email author
  • L. I. Valuev
    • 1
  • L. V. Vanchugova
    • 1
  • I. V. Obydennova
    • 1
  1. 1.Topchiev Institute of Petrochemical Synthesis, Russian Academy of SciencesMoscowRussia

Personalised recommendations